<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Hoyle, Brian</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Kashyap, Sangeeta R.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Bariatric Surgery for Treatment of Type 2 Diabetes in Obese Patients: 3-Year Outcomes (STAMPEDE)</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-05-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">25-26</style></pages><abstract><style  face="normal" font="default" size="100%">Of the more than 25 million Americans with type 2 diabetes mellitus (T2DM), fewer than half can attain adequate glycemic control. Bariatric surgery has resulted in improved glycemic and cardiovascular risk factor control in observational and short-term randomized studies, including the 1- year results of the Surgical Treatment and Medications Potentially Eradicate Diabetes Efficiently trial [STAMPEDE; Schauer P et al. N Engl J Med 2012]. The 3-year STAMPEDE data compared the effect of bariatric surgery with intensive medical therapy versus intensive medical therapy alone on glycemic control [Schauer PR et al. N Engl J Med 2014].</style></abstract><number><style face="normal" font="default" size="100%">4</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>